Advancing Drug Development through Molecular Imaging (ADDMI) Interest Group

The ADDMI Interest Group addresses the pipeline issue for drug development, encourages and fosters multidisciplinary research towards advancing drug development through Molecular Imaging (ADDMI), provides a platform for productive discussions around drug development through molecular imaging and its challenges, pursues a common goal of developing ADDMI, helps facilitate the successful development of ADDMI, provides a platform to address clinical manufacturing issues and Phase 1 clinical trials, and establishes ADDMI/WMIS as a ‘central body’ to help address regulatory issues related to ADDMI.

WMIS invites you to find your place to grow, collaborate and make a difference – join the ADDMI Interest Group today.

Members: Interest Groups are open to current WMIS Members. There is an annual Interest Group membership fee of $20 which is requested to help offset administrative costs. To join an interest group, please click the button below.

If you are not a current WMIS member, please click the button below and create a new profile to join WMIS and join interest groups.


Mission Statement

To globally engage and advance discovery and clinical application of molecular imaging approaches for the development of molecular imaging based companion diagnostics for therapeutics.